| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein kinase activity | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 NME2 MAP3K2 | 3.74e-05 | 600 | 98 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | NTRK3 POLR2A ROR1 NME2P1 ERVK-7 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 NME2 MAP3K2 | 5.08e-05 | 938 | 98 | 15 | GO:0016772 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 7.42e-05 | 17 | 98 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 7.42e-05 | 17 | 98 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | kinase activity | NTRK3 ROR1 NME2P1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 NME2 MAP3K2 | 9.11e-05 | 764 | 98 | 13 | GO:0016301 |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.54e-04 | 103 | 98 | 5 | GO:0004725 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 NME2 MAP3K2 | 1.82e-04 | 709 | 98 | 12 | GO:0016773 |
| GeneOntologyMolecularFunction | exogenous lipid antigen binding | 2.36e-04 | 5 | 98 | 2 | GO:0030884 | |
| GeneOntologyMolecularFunction | endogenous lipid antigen binding | 2.36e-04 | 5 | 98 | 2 | GO:0030883 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 3.40e-04 | 189 | 98 | 6 | GO:0004721 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 3.47e-04 | 446 | 98 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | lipid antigen binding | 3.53e-04 | 6 | 98 | 2 | GO:0030882 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.78e-04 | 125 | 98 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 4.19e-04 | 363 | 98 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.14e-04 | 34 | 98 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 7.89e-04 | 37 | 98 | 3 | GO:0004190 | |
| GeneOntologyMolecularFunction | chloride channel activity | 8.51e-04 | 86 | 98 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 8.54e-04 | 38 | 98 | 3 | GO:0070001 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 8.93e-04 | 151 | 98 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 1.05e-03 | 10 | 98 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.27e-03 | 11 | 98 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.49e-03 | 46 | 98 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.55e-03 | 171 | 98 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.66e-03 | 103 | 98 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 2.09e-03 | 14 | 98 | 2 | GO:0051880 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 2.40e-03 | 15 | 98 | 2 | GO:0019215 | |
| GeneOntologyMolecularFunction | phosphatase activity | 2.92e-03 | 287 | 98 | 6 | GO:0016791 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.09e-03 | 17 | 98 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 3.09e-03 | 17 | 98 | 2 | GO:0008308 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | MAG NTRK3 ROR1 HLA-E ADGRB3 RYK PTPRD PTPRF FIG4 PTPRS PAK1 PAK2 PAK3 NME2 CNTN2 | 1.93e-07 | 612 | 98 | 15 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MAG NTRK3 ROR1 HLA-E ADGRB3 SAXO1 RYK PTPRD PTPRF FIG4 PTPRS PAK1 PAK2 PAK3 NME2 CNTN2 | 2.26e-06 | 846 | 98 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAG NTRK3 ROR1 HLA-E ADGRB3 SAXO1 RYK PTPRD PTPRF FIG4 PTPRS PAK1 PAK2 PAK3 NME2 CNTN2 | 2.92e-06 | 863 | 98 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 3.59e-06 | 7 | 98 | 3 | GO:0007185 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 3.75e-06 | 192 | 98 | 8 | GO:0050770 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | COL4A3 COL4A5 COL4A6 NTRK3 ROR1 RYK LONP1 PTPRF SULF1 ADGRE3 PAK1 PAK2 PAK3 MVB12B | 1.15e-05 | 747 | 98 | 14 | GO:0007169 |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 1.99e-05 | 34 | 98 | 4 | GO:0097107 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 2.22e-05 | 12 | 98 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 5.62e-05 | 44 | 98 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 6.71e-05 | 46 | 98 | 4 | GO:1904861 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 8.06e-05 | 18 | 98 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 1.30e-04 | 21 | 98 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 1.39e-04 | 104 | 98 | 5 | GO:0030516 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | COL4A3 COL4A5 COL4A6 NTRK3 ROR1 PTPRU RYK LONP1 PTPRD PTPRF SULF1 ADGRE3 PAK1 PAK2 PAK3 MVB12B | 1.41e-04 | 1186 | 98 | 16 | GO:0007167 |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 1.45e-04 | 105 | 98 | 5 | GO:0048708 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 1.67e-04 | 58 | 98 | 4 | GO:0097106 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 1.72e-04 | 23 | 98 | 3 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 1.72e-04 | 23 | 98 | 3 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 1.72e-04 | 23 | 98 | 3 | GO:1990840 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | MAG NTRK3 ADGRB3 RYK PTPRD PTPRF FIG4 PTPRS LRRTM2 PAK1 PAK3 | 1.86e-04 | 625 | 98 | 11 | GO:0051960 |
| GeneOntologyBiologicalProcess | antigen processing and presentation, endogenous lipid antigen via MHC class Ib | 2.21e-04 | 5 | 98 | 2 | GO:0048006 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 2.21e-04 | 5 | 98 | 2 | GO:0071641 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 2.22e-04 | 25 | 98 | 3 | GO:0009220 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.22e-04 | 25 | 98 | 3 | GO:0002475 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 2.50e-04 | 26 | 98 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 2.50e-04 | 26 | 98 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 2.80e-04 | 27 | 98 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.92e-04 | 122 | 98 | 5 | GO:0061387 | |
| GeneOntologyBiologicalProcess | axon regeneration | 3.27e-04 | 69 | 98 | 4 | GO:0031103 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 3.65e-04 | 71 | 98 | 4 | GO:0099084 | |
| GeneOntologyBiologicalProcess | synapse organization | COL4A5 NTRK3 ADGRB3 RYK PTPRD PTPRF PTPRS LRRTM2 PAK1 PAK3 CNTN2 | 4.07e-04 | 685 | 98 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | antigen processing and presentation, exogenous lipid antigen via MHC class Ib | 4.62e-04 | 7 | 98 | 2 | GO:0048007 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of lipid antigen via MHC class Ib | 4.62e-04 | 7 | 98 | 2 | GO:0048003 | |
| GeneOntologyBiologicalProcess | axon extension | 4.65e-04 | 135 | 98 | 5 | GO:0048675 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous antigen | 4.67e-04 | 32 | 98 | 3 | GO:0019883 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 5.12e-04 | 33 | 98 | 3 | GO:0006221 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 5.59e-04 | 34 | 98 | 3 | GO:0009218 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation | 5.59e-04 | 34 | 98 | 3 | GO:0035335 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 5.67e-04 | 141 | 98 | 5 | GO:0060996 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 5.75e-04 | 494 | 98 | 9 | GO:0031346 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 6.02e-04 | 81 | 98 | 4 | GO:0031102 | |
| GeneOntologyBiologicalProcess | regulation of macrophage inflammatory protein 1 alpha production | 6.14e-04 | 8 | 98 | 2 | GO:0071640 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | CYBB MAG COL4A3 NTRK3 ADGRB3 RYK PTPRD PTPRF PTPRS SULF1 PAK1 PAK2 PAK3 CNTN2 | 6.26e-04 | 1090 | 98 | 14 | GO:0022603 |
| GeneOntologyBiologicalProcess | cell junction organization | COL4A5 NTRK3 ADGRB3 RYK PTPRD PTPRF PTPRS LRRTM2 PAK1 PAK2 PAK3 ILDR1 CNTN2 | 6.97e-04 | 974 | 98 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 7.55e-04 | 86 | 98 | 4 | GO:0051965 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 7.78e-04 | 38 | 98 | 3 | GO:0030517 | |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 7.87e-04 | 9 | 98 | 2 | GO:0071608 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 8.44e-04 | 748 | 98 | 11 | GO:0048667 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 8.54e-04 | 418 | 98 | 8 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of axon regeneration | 9.05e-04 | 40 | 98 | 3 | GO:0048679 | |
| GeneOntologyBiologicalProcess | transepithelial chloride transport | 9.81e-04 | 10 | 98 | 2 | GO:0030321 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 9.81e-04 | 10 | 98 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 1.01e-03 | 93 | 98 | 4 | GO:0099068 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated cytotoxicity | 1.04e-03 | 42 | 98 | 3 | GO:0001916 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.04e-03 | 42 | 98 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | neuron projection development | MAG NTRK3 ROR1 HLA-E ADGRB3 RYK PTPRD PTPRF FIG4 PTPRS PAK1 PAK2 PAK3 NME2 CNTN2 | 1.05e-03 | 1285 | 98 | 15 | GO:0031175 |
| GeneOntologyBiologicalProcess | dendrite development | 1.10e-03 | 335 | 98 | 7 | GO:0016358 | |
| GeneOntologyBiologicalProcess | pyrimidine-containing compound biosynthetic process | 1.12e-03 | 43 | 98 | 3 | GO:0072528 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 1.12e-03 | 43 | 98 | 3 | GO:0048710 | |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 1.20e-03 | 11 | 98 | 2 | GO:0006228 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.22e-03 | 249 | 98 | 6 | GO:0010976 | |
| GeneOntologyBiologicalProcess | regeneration | 1.29e-03 | 252 | 98 | 6 | GO:0031099 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.86e-06 | 6 | 96 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 5.17e-06 | 8 | 96 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 5.17e-06 | 8 | 96 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 5.17e-06 | 8 | 96 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | postsynaptic membrane | NTRK3 ADGRB3 RYK SLC6A9 SLC6A11 PTPRF KCNC4 PTPRS LRRTM2 CNTN2 | 1.71e-05 | 405 | 96 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | NTRK3 ADGRB3 RYK SLC6A9 SLC6A11 PTPRD PTPRF KCNC4 PTPRS LRRTM2 CNTN2 | 7.47e-05 | 583 | 96 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.18e-04 | 21 | 96 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.45e-04 | 523 | 96 | 10 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynaptic density | 2.31e-04 | 451 | 96 | 9 | GO:0014069 | |
| GeneOntologyCellularComponent | basement membrane | 2.49e-04 | 122 | 96 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | asymmetric synapse | 3.48e-04 | 477 | 96 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.11e-04 | 503 | 96 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | postsynapse | NTRK3 ADGRB3 RYK SLC6A9 SLC6A11 PTPRF KCNC4 PTPRS LRRTM2 PAK1 PAK2 PAK3 CNTN2 | 7.60e-04 | 1018 | 96 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 7.91e-04 | 157 | 96 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | excitatory synapse | 1.50e-03 | 107 | 96 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.76e-03 | 277 | 96 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.29e-03 | 57 | 96 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.36e-03 | 201 | 96 | 5 | GO:0099634 | |
| HumanPheno | Nasogastric tube feeding | 1.40e-05 | 42 | 39 | 5 | HP:0040288 | |
| HumanPheno | Lenticonus | 4.80e-05 | 10 | 39 | 3 | HP:0001142 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 5.71e-05 | 2 | 39 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 5.71e-05 | 2 | 39 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 5.71e-05 | 2 | 39 | 2 | HP:0006756 | |
| HumanPheno | Glomerular basement membrane lamellation | 1.71e-04 | 3 | 39 | 2 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 1.71e-04 | 3 | 39 | 2 | HP:0011501 | |
| HumanPheno | Vulvar neoplasm | 1.71e-04 | 3 | 39 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 1.71e-04 | 3 | 39 | 2 | HP:0032141 | |
| HumanPheno | Abnormal drug response | 1.71e-04 | 3 | 39 | 2 | HP:0020169 | |
| HumanPheno | Hypokalemic hypochloremic metabolic alkalosis | 1.71e-04 | 3 | 39 | 2 | HP:0004909 | |
| HumanPheno | Severe failure to thrive | 2.62e-04 | 17 | 39 | 3 | HP:0001525 | |
| Domain | IG_LIKE | MAG NTRK3 ROR1 HLA-E SIRPB1 PTPRU CD1A CD1E PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 1.59e-07 | 491 | 94 | 14 | PS50835 |
| Domain | Ig-like_dom | MAG NTRK3 ROR1 HLA-E SIRPB1 PTPRU CD1A CD1E PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 2.14e-07 | 503 | 94 | 14 | IPR007110 |
| Domain | - | MAG EPM2A NTRK3 ROR1 HLA-E SIRPB1 PTPRU CD1A CD1E PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 1.06e-06 | 663 | 94 | 15 | 2.60.40.10 |
| Domain | Ig-like_fold | MAG EPM2A NTRK3 ROR1 HLA-E SIRPB1 PTPRU CD1A CD1E PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 2.30e-06 | 706 | 94 | 15 | IPR013783 |
| Domain | C4 | 2.44e-06 | 6 | 94 | 3 | SM00111 | |
| Domain | - | 2.44e-06 | 6 | 94 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 2.44e-06 | 6 | 94 | 3 | IPR001442 | |
| Domain | C4 | 2.44e-06 | 6 | 94 | 3 | PF01413 | |
| Domain | PAK_BD | 2.44e-06 | 6 | 94 | 3 | IPR033923 | |
| Domain | NC1_IV | 2.44e-06 | 6 | 94 | 3 | PS51403 | |
| Domain | TYR_PHOSPHATASE_2 | 5.03e-06 | 87 | 94 | 6 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 5.03e-06 | 87 | 94 | 6 | IPR000387 | |
| Domain | Ig_I-set | 5.22e-06 | 190 | 94 | 8 | IPR013098 | |
| Domain | I-set | 5.22e-06 | 190 | 94 | 8 | PF07679 | |
| Domain | - | 6.96e-06 | 92 | 94 | 6 | 3.90.190.10 | |
| Domain | IG | MAG NTRK3 ROR1 SIRPB1 PTPRU PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 8.63e-06 | 421 | 94 | 11 | SM00409 |
| Domain | Ig_sub | MAG NTRK3 ROR1 SIRPB1 PTPRU PTPRD PTPRF HMCN1 PTPRS ILDR1 CNTN2 | 8.63e-06 | 421 | 94 | 11 | IPR003599 |
| Domain | Prot-tyrosine_phosphatase-like | 1.06e-05 | 99 | 94 | 6 | IPR029021 | |
| Domain | PROTEIN_KINASE_ATP | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 MAP3K2 | 1.93e-05 | 459 | 94 | 11 | PS00107 |
| Domain | Cl_channel-K | 2.51e-05 | 2 | 94 | 2 | IPR002250 | |
| Domain | - | 2.63e-05 | 12 | 94 | 3 | 3.90.810.10 | |
| Domain | PTPc | 3.13e-05 | 36 | 94 | 4 | SM00194 | |
| Domain | Tyr_Pase_AS | 3.33e-05 | 73 | 94 | 5 | IPR016130 | |
| Domain | Prot_kinase_dom | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 MAP3K2 | 3.45e-05 | 489 | 94 | 11 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 MAP3K2 | 3.71e-05 | 493 | 94 | 11 | PS50011 |
| Domain | TYR_PHOSPHATASE_PTP | 4.32e-05 | 39 | 94 | 4 | PS50055 | |
| Domain | PTPase_domain | 5.28e-05 | 41 | 94 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 5.28e-05 | 41 | 94 | 4 | PF00102 | |
| Domain | PBD | 6.59e-05 | 16 | 94 | 3 | SM00285 | |
| Domain | TYR_PHOSPHATASE_1 | 7.32e-05 | 86 | 94 | 5 | PS00383 | |
| Domain | PBD | 7.98e-05 | 17 | 94 | 3 | PF00786 | |
| Domain | Kinase-like_dom | NTRK3 ROR1 RYK STK10 TNNI3K CSNK1D CSNK1E PAK1 PAK2 PAK3 MAP3K2 | 8.70e-05 | 542 | 94 | 11 | IPR011009 |
| Domain | Protein_kinase_ATP_BS | 1.24e-04 | 379 | 94 | 9 | IPR017441 | |
| Domain | CRIB | 1.32e-04 | 20 | 94 | 3 | PS50108 | |
| Domain | CRIB_dom | 1.54e-04 | 21 | 94 | 3 | IPR000095 | |
| Domain | C1-set | 1.57e-04 | 54 | 94 | 4 | PF07654 | |
| Domain | IGc1 | 1.81e-04 | 56 | 94 | 4 | SM00407 | |
| Domain | IGc2 | 1.85e-04 | 235 | 94 | 7 | SM00408 | |
| Domain | Ig_sub2 | 1.85e-04 | 235 | 94 | 7 | IPR003598 | |
| Domain | Ig_C1-set | 2.07e-04 | 58 | 94 | 4 | IPR003597 | |
| Domain | PTPc_motif | 2.22e-04 | 59 | 94 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.22e-04 | 59 | 94 | 4 | IPR003595 | |
| Domain | - | 2.31e-04 | 24 | 94 | 3 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.31e-04 | 24 | 94 | 3 | IPR011161 | |
| Domain | MHC_I_3 | 3.71e-04 | 6 | 94 | 2 | PF16497 | |
| Domain | ig | 3.97e-04 | 190 | 94 | 6 | PF00047 | |
| Domain | Immunoglobulin | 3.97e-04 | 190 | 94 | 6 | IPR013151 | |
| Domain | Ser/Thr_kinase_AS | 4.39e-04 | 357 | 94 | 8 | IPR008271 | |
| Domain | PROTEIN_KINASE_ST | 4.82e-04 | 362 | 94 | 8 | PS00108 | |
| Domain | WASP_C | 5.18e-04 | 7 | 94 | 2 | IPR011026 | |
| Domain | Cl-channel_core | 8.82e-04 | 9 | 94 | 2 | IPR014743 | |
| Domain | NDP_KINASES | 8.82e-04 | 9 | 94 | 2 | PS00469 | |
| Domain | - | 8.82e-04 | 9 | 94 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 8.82e-04 | 9 | 94 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 8.82e-04 | 9 | 94 | 2 | IPR001807 | |
| Domain | MHC_I/II-like_Ag-recog | 9.17e-04 | 38 | 94 | 3 | IPR011162 | |
| Domain | NDK | 1.10e-03 | 10 | 94 | 2 | SM00562 | |
| Domain | NDK | 1.10e-03 | 10 | 94 | 2 | PF00334 | |
| Domain | GAIN_dom_N | 1.34e-03 | 11 | 94 | 2 | IPR032471 | |
| Domain | GAIN | 1.34e-03 | 11 | 94 | 2 | PF16489 | |
| Domain | fn3 | 1.36e-03 | 162 | 94 | 5 | PF00041 | |
| Domain | Nucleoside_diP_kinase | 1.60e-03 | 12 | 94 | 2 | IPR001564 | |
| Domain | CTDL_fold | 2.09e-03 | 107 | 94 | 4 | IPR016187 | |
| Domain | FN3 | 2.43e-03 | 185 | 94 | 5 | SM00060 | |
| Domain | CBS | 2.87e-03 | 16 | 94 | 2 | SM00116 | |
| Domain | Pkinase | 3.11e-03 | 381 | 94 | 7 | PF00069 | |
| Domain | FN3 | 3.33e-03 | 199 | 94 | 5 | PS50853 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.64e-03 | 18 | 94 | 2 | PS00754 | |
| Domain | SNF | 4.05e-03 | 19 | 94 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.05e-03 | 19 | 94 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.05e-03 | 19 | 94 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 4.05e-03 | 19 | 94 | 2 | IPR000175 | |
| Domain | Pkinase_Tyr | 4.10e-03 | 129 | 94 | 4 | PF07714 | |
| Domain | FN3_dom | 4.10e-03 | 209 | 94 | 5 | IPR003961 | |
| Domain | CBS_dom | 4.49e-03 | 20 | 94 | 2 | IPR000644 | |
| Domain | CBS | 4.49e-03 | 20 | 94 | 2 | PF00571 | |
| Domain | CBS | 4.49e-03 | 20 | 94 | 2 | PS51371 | |
| Domain | MHC_I | 4.95e-03 | 21 | 94 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 4.95e-03 | 21 | 94 | 2 | IPR001039 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.36e-06 | 20 | 75 | 4 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.36e-06 | 20 | 75 | 4 | MM14991 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.69e-05 | 10 | 75 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.69e-05 | 10 | 75 | 3 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 2.31e-05 | 11 | 75 | 3 | M15422 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.78e-05 | 67 | 75 | 5 | MM15327 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.07e-05 | 12 | 75 | 3 | MM1526 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 3.07e-05 | 12 | 75 | 3 | M13618 | |
| Pathway | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | 3.07e-05 | 12 | 75 | 3 | MM14994 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.98e-05 | 13 | 75 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 3.98e-05 | 13 | 75 | 3 | M12950 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 3.98e-05 | 13 | 75 | 3 | M6322 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 5.05e-05 | 14 | 75 | 3 | MM15029 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.05e-05 | 14 | 75 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 5.05e-05 | 14 | 75 | 3 | M6487 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.29e-05 | 15 | 75 | 3 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.29e-05 | 15 | 75 | 3 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.99e-05 | 418 | 75 | 10 | MM15587 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 7.71e-05 | 16 | 75 | 3 | M16498 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 9.32e-05 | 17 | 75 | 3 | MM15215 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 9.80e-05 | 87 | 75 | 5 | M27617 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.05e-04 | 439 | 75 | 10 | M42563 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | CYBB COL4A3 COL4A5 NTRK3 POLR2A PTPRU PTPRF PTPRS PAK1 PAK2 PAK3 | 1.09e-04 | 532 | 75 | 11 | M27870 |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.11e-04 | 18 | 75 | 3 | MM15024 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.11e-04 | 18 | 75 | 3 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.11e-04 | 18 | 75 | 3 | MM14882 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 1.32e-04 | 19 | 75 | 3 | M27310 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 1.53e-04 | 51 | 75 | 4 | M39721 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.55e-04 | 20 | 75 | 3 | M15394 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.55e-04 | 20 | 75 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.80e-04 | 21 | 75 | 3 | M27736 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.80e-04 | 21 | 75 | 3 | M27485 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.80e-04 | 21 | 75 | 3 | M27494 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.37e-04 | 23 | 75 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.37e-04 | 23 | 75 | 3 | MM1427 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.37e-04 | 23 | 75 | 3 | MM15222 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 3.86e-04 | 27 | 75 | 3 | MM14809 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.86e-04 | 27 | 75 | 3 | M27422 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 5.30e-04 | 30 | 75 | 3 | M27216 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 5.30e-04 | 30 | 75 | 3 | M76 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 5.30e-04 | 30 | 75 | 3 | MM15170 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.84e-04 | 31 | 75 | 3 | MM1343 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 6.09e-04 | 73 | 75 | 4 | MM15285 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.42e-04 | 32 | 75 | 3 | MM14924 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 7.04e-04 | 33 | 75 | 3 | M6220 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 7.04e-04 | 33 | 75 | 3 | M11725 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.10e-04 | 76 | 75 | 4 | M27219 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 7.69e-04 | 34 | 75 | 3 | MM14992 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 8.38e-04 | 35 | 75 | 3 | M16801 | |
| Pathway | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | 1.15e-03 | 39 | 75 | 3 | M16523 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.15e-03 | 39 | 75 | 3 | MM15607 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT | 1.24e-03 | 40 | 75 | 3 | M39798 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 1.24e-03 | 40 | 75 | 3 | M41816 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.33e-03 | 41 | 75 | 3 | MM15538 | |
| Pathway | REACTOME_HIV_INFECTION | 1.42e-03 | 231 | 75 | 6 | M12469 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.43e-03 | 42 | 75 | 3 | M7169 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 1.49e-03 | 11 | 75 | 2 | M27681 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 1.49e-03 | 11 | 75 | 2 | MM15402 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.51e-03 | 93 | 75 | 4 | M27572 | |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 1.53e-03 | 43 | 75 | 3 | M39788 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 1.53e-03 | 43 | 75 | 3 | M53 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.64e-03 | 44 | 75 | 3 | M27812 | |
| Pathway | SIG_CHEMOTAXIS | 1.75e-03 | 45 | 75 | 3 | M5193 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.86e-03 | 46 | 75 | 3 | M198 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.98e-03 | 47 | 75 | 3 | M39829 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.00e-03 | 335 | 75 | 7 | MM14503 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 2.10e-03 | 13 | 75 | 2 | M18009 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.20e-03 | 103 | 75 | 4 | MM14752 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.37e-03 | 50 | 75 | 3 | MM14796 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 2.44e-03 | 106 | 75 | 4 | M27077 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.51e-03 | 51 | 75 | 3 | MM14967 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.80e-03 | 53 | 75 | 3 | MM14566 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 2.80e-03 | 15 | 75 | 2 | MM14797 | |
| Pathway | REACTOME_TCR_SIGNALING | 2.88e-03 | 111 | 75 | 4 | MM14803 | |
| Pathway | PID_RAC1_PATHWAY | 2.95e-03 | 54 | 75 | 3 | M278 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.98e-03 | 112 | 75 | 4 | MM15214 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 3.11e-03 | 55 | 75 | 3 | M41815 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.17e-03 | 114 | 75 | 4 | MM14571 | |
| Pathway | REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS | 3.61e-03 | 17 | 75 | 2 | M27104 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 3.61e-03 | 17 | 75 | 2 | M27918 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 3.80e-03 | 59 | 75 | 3 | M39750 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.80e-03 | 59 | 75 | 3 | M27218 | |
| Pubmed | 1.01e-08 | 26 | 98 | 5 | 36178190 | ||
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 25624497 | ||
| Pubmed | 2.05e-08 | 162 | 98 | 8 | 25826454 | ||
| Pubmed | Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. | 2.17e-08 | 3 | 98 | 3 | 10075701 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 15182717 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 23335370 | ||
| Pubmed | Group I Paks as therapeutic targets in NF2-deficient meningioma. | 2.17e-08 | 3 | 98 | 3 | 25596744 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.17e-08 | 3 | 98 | 3 | 31985401 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 20139422 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.17e-08 | 3 | 98 | 3 | 33656439 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 18507705 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 2.17e-08 | 3 | 98 | 3 | 27377778 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 38785043 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 11278486 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.88e-08 | 12 | 98 | 4 | 9624153 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 8524829 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 10461188 | ||
| Pubmed | CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. | 8.66e-08 | 4 | 98 | 3 | 19819308 | |
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 15878328 | ||
| Pubmed | CES1 POLR2A USP24 PTPRU SULT2B1 KCNC4 CSNK1D CSNK1E PAK1 PAK2 CORO6 EIF3C MMP16 | 1.44e-07 | 730 | 98 | 13 | 34857952 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 10777529 | ||
| Pubmed | Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. | 2.16e-07 | 5 | 98 | 3 | 23509247 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 22357843 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 4.31e-07 | 6 | 98 | 3 | 9506531 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 19273906 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 12237306 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 2426947 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 33482876 | ||
| Pubmed | Pak1 is involved in dendrite initiation as a downstream effector of Rac1 in cortical neurons. | 4.31e-07 | 6 | 98 | 3 | 12213441 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 4.31e-07 | 6 | 98 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 4.31e-07 | 6 | 98 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 4.31e-07 | 6 | 98 | 3 | 6389236 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 4.31e-07 | 6 | 98 | 3 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 4.31e-07 | 6 | 98 | 3 | 9673377 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 4.31e-07 | 6 | 98 | 3 | 19275937 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 6988303 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 29073098 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 11711546 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 12376545 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 7.53e-07 | 7 | 98 | 3 | 8006028 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 10416788 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 1724753 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 17418794 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 22003931 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 3997552 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 29422532 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 1377218 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 37591863 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 28637841 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.20e-06 | 8 | 98 | 3 | 10970885 | |
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 9878537 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 12101409 | ||
| Pubmed | Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain. | 2.57e-06 | 10 | 98 | 3 | 18653452 | |
| Pubmed | 2.57e-06 | 10 | 98 | 3 | 9136074 | ||
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 3.52e-06 | 11 | 98 | 3 | 7500359 | |
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 7832766 | ||
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 3.52e-06 | 11 | 98 | 3 | 9731539 | |
| Pubmed | 3.52e-06 | 11 | 98 | 3 | 10352232 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EPM2A PSMB4 PTPRU PTPRD STYX PTPRF PTPRS CSNK1D CSNK1E EIF3C NUP188 PRRC2A ABTB2 | 3.59e-06 | 974 | 98 | 13 | 28675297 |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 18824165 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 4.69e-06 | 12 | 98 | 3 | 12180907 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 23559827 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 4.69e-06 | 12 | 98 | 3 | 15837576 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 16024816 | ||
| Pubmed | Loss of ARHGEF6 Causes Hair Cell Stereocilia Deficits and Hearing Loss in Mice. | 6.08e-06 | 13 | 98 | 3 | 30333726 | |
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 18586681 | ||
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 12878203 | ||
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 7.86e-06 | 2 | 98 | 2 | 8544406 | |
| Pubmed | Activation of PAK1/2 during the shedding of platelet microvesicles. | 7.86e-06 | 2 | 98 | 2 | 20523167 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20954848 | ||
| Pubmed | CD1A and CD1E gene polymorphisms are associated with susceptibility to multiple sclerosis. | 7.86e-06 | 2 | 98 | 2 | 21496400 | |
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 7.86e-06 | 2 | 98 | 2 | 27335120 | |
| Pubmed | PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions. | 7.86e-06 | 2 | 98 | 2 | 31748572 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19043076 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8812470 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 3053166 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25919862 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23622267 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24863058 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24424021 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 7.86e-06 | 2 | 98 | 2 | 9916798 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9916791 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19435845 | ||
| Pubmed | Salmonella evades D-amino acid oxidase to promote infection in neutrophils. | 7.86e-06 | 2 | 98 | 2 | 25425233 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21262467 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 30858169 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21115725 | ||
| Pubmed | Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. | 7.86e-06 | 2 | 98 | 2 | 8356449 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9632646 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 7488060 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29301656 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 35177655 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 7.86e-06 | 2 | 98 | 2 | 38069401 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15047871 | ||
| Pubmed | Expression of p21-activated kinases 1 and 3 is altered in the brain of subjects with depression. | 7.86e-06 | 2 | 98 | 2 | 27474226 | |
| Interaction | OMG interactions | 2.58e-07 | 13 | 90 | 4 | int:OMG | |
| Interaction | PTPRD interactions | 1.99e-06 | 131 | 90 | 7 | int:PTPRD | |
| Interaction | MICU2 interactions | 3.98e-06 | 94 | 90 | 6 | int:MICU2 | |
| Interaction | PTPRS interactions | 5.59e-06 | 153 | 90 | 7 | int:PTPRS | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-07 | 161 | 65 | 8 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.70e-07 | 21 | 65 | 4 | 813 | |
| GeneFamily | C1-set domain containing | 1.54e-05 | 42 | 65 | 4 | 591 | |
| GeneFamily | Fibronectin type III domain containing | 2.74e-04 | 160 | 65 | 5 | 555 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.98e-04 | 40 | 65 | 3 | 321 | |
| GeneFamily | Chloride voltage-gated channels | 5.62e-04 | 10 | 65 | 2 | 302 | |
| GeneFamily | Collagens | 6.03e-04 | 46 | 65 | 3 | 490 | |
| GeneFamily | Atypical dual specificity phosphatases | 1.88e-03 | 18 | 65 | 2 | 896 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CYBB MAG AMPD1 CES1 NTRK3 PSMB4 HLA-E PTPRU SLC6A9 SLC6A11 PTPRF CLCNKA CLCNKB KCNC4 CSNK1D PAK3 CNTN2 | 2.76e-06 | 1281 | 94 | 17 | M1884 |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 7.66e-06 | 199 | 94 | 7 | M5263 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED | 9.60e-06 | 12 | 94 | 3 | M47998 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.28e-05 | 40 | 94 | 4 | M5887 | |
| Coexpression | ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION | 1.56e-05 | 87 | 94 | 5 | M18322 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.73e-05 | 313 | 94 | 8 | M40228 | |
| Coexpression | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER | 3.07e-05 | 100 | 94 | 5 | M14670 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP | 3.94e-05 | 174 | 94 | 6 | M6817 | |
| Coexpression | FERRANDO_HOX11_NEIGHBORS | 7.51e-05 | 23 | 94 | 3 | M2059 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP | 8.30e-05 | 199 | 94 | 6 | M5266 | |
| Coexpression | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY | 1.09e-04 | 26 | 94 | 3 | M16488 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 1.09e-04 | 26 | 94 | 3 | M47999 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.90e-05 | 127 | 92 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-07 | 188 | 93 | 7 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-07 | 189 | 93 | 7 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.72e-07 | 194 | 93 | 7 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.72e-07 | 194 | 93 | 7 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.05e-07 | 199 | 93 | 7 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | COPD-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 1.09e-06 | 160 | 93 | 6 | 1b73a14ad6546d9f2812c19081278a79260abeae | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 173 | 93 | 6 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.30e-06 | 182 | 93 | 6 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 183 | 93 | 6 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 187 | 93 | 6 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.69e-06 | 187 | 93 | 6 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 188 | 93 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 188 | 93 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Promonocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.77e-06 | 188 | 93 | 6 | 2ae945d96a011f246d04a42bcd6ef443232b03f4 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 2.77e-06 | 188 | 93 | 6 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 189 | 93 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.86e-06 | 189 | 93 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.86e-06 | 189 | 93 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 189 | 93 | 6 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.94e-06 | 190 | 93 | 6 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 190 | 93 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.94e-06 | 190 | 93 | 6 | b8c131020d20005cd9f23d26312196f62c958074 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-06 | 191 | 93 | 6 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.13e-06 | 192 | 93 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.32e-06 | 194 | 93 | 6 | a0cfc8c1cdc0722db39170e4417615b6e6b85041 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 194 | 93 | 6 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.42e-06 | 195 | 93 | 6 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-06 | 195 | 93 | 6 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 196 | 93 | 6 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.52e-06 | 196 | 93 | 6 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.52e-06 | 196 | 93 | 6 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.52e-06 | 196 | 93 | 6 | aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.63e-06 | 197 | 93 | 6 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.63e-06 | 197 | 93 | 6 | e862561f61a1ae1ec858b34f8d9c9a7dc8894104 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-06 | 197 | 93 | 6 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.63e-06 | 197 | 93 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | a183afe4c2034323f77abfa080f359d67da35e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | 731a90f7e68b19e387499d63e3979af78b503b0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | 43a2ce64fa309bac89a44ea320e87ae2cc39f782 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | 97ae237f955fd5fbd01d06aafe89ef9e6f777a9a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | 27f0654fb0857e93f030e1a4b1c307b31576bbcd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 198 | 93 | 6 | fef9a4c96450078527b94d25e681410e4ea01b13 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.84e-06 | 199 | 93 | 6 | 02256d86541be6851634283047fdc05fdf095114 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.84e-06 | 199 | 93 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(50)_cDC2|Sigmoid / shred on region, Cell_type, and subtype | 3.84e-06 | 199 | 93 | 6 | 402af84db90d8a49d67cf44c24766aefb00fd716 | |
| ToppCell | PBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.84e-06 | 199 | 93 | 6 | 27667838e065370d4536eaaf5b42ad322a714b96 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-06 | 199 | 93 | 6 | aa30a57c0907d012942e7babdbff6ea4d01d7798 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-06 | 199 | 93 | 6 | 7e5a56bb2ac441a8fa4ad0b928f9c0c82d128190 | |
| ToppCell | COVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class | 3.84e-06 | 199 | 93 | 6 | d0c230c3699955a80630b63ed18c770444c5dfe5 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Sigmoid / Region, Cell class and subclass | 3.84e-06 | 199 | 93 | 6 | cd74db6db694b68f81dcf9d9342d125d00357ec1 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.84e-06 | 199 | 93 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.96e-06 | 200 | 93 | 6 | 4984d27b3768be3b8fca3391cd2b7ab1749e2913 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-06 | 200 | 93 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-06 | 200 | 93 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class | 3.96e-06 | 200 | 93 | 6 | 247040492b3c327f4144fc94cf210dc04eecc7b0 | |
| ToppCell | (09)_Ionocytes|World / shred by cell type and Timepoint | 9.49e-06 | 135 | 93 | 5 | 237b9b646513ca6e4b754c0da95d24015b3661f7 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.09e-05 | 139 | 93 | 5 | 4f4b447e85dda69058d9edbcfe37e55751dd90a6 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 139 | 93 | 5 | 1cc48af58a2443db3c6798080b9c4bc70000cf87 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.21e-05 | 142 | 93 | 5 | 1eecbec805a873fa3539df0574670cf73c18c7b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 150 | 93 | 5 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-05 | 156 | 93 | 5 | 03f3c5ffb27758fe63797143fcc938f9e8a4e10d | |
| ToppCell | COPD-Myeloid-DC_Langerhans|COPD / Disease state, Lineage and Cell class | 2.03e-05 | 158 | 93 | 5 | 71af1319eec34bf7bc9361ec9ef720c280ce97d1 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD1c+_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.09e-05 | 159 | 93 | 5 | 35a63ca521635389a1edc7c81157793b8ad24d38 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 160 | 93 | 5 | 86fde32f096eaf9ea3677f57169cdcc0a57bb8dd | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 162 | 93 | 5 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-05 | 163 | 93 | 5 | 4be3158f2a0ab460cfea8080a7370922910b5da9 | |
| ToppCell | COPD-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 2.43e-05 | 164 | 93 | 5 | a07c6e13c07a90bc37db0915eb14931eb8309a1e | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 2.57e-05 | 166 | 93 | 5 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.80e-05 | 169 | 93 | 5 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-05 | 172 | 93 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-05 | 173 | 93 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-05 | 173 | 93 | 5 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-05 | 173 | 93 | 5 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-05 | 174 | 93 | 5 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.22e-05 | 174 | 93 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.31e-05 | 175 | 93 | 5 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.31e-05 | 175 | 93 | 5 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 176 | 93 | 5 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 176 | 93 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | BAL-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 3.50e-05 | 177 | 93 | 5 | 939487a05311b66edfc3f44a7955fbf25266d6bf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 177 | 93 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.59e-05 | 178 | 93 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.69e-05 | 179 | 93 | 5 | 8c50e13927c09de05c86cd90dd6f71cee004b0d3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 180 | 93 | 5 | d685fa2b013bc085dbef7c40956ed3043f83e483 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 3.89e-05 | 181 | 93 | 5 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 181 | 93 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-05 | 181 | 93 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.89e-05 | 181 | 93 | 5 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.99e-05 | 182 | 93 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.99e-05 | 182 | 93 | 5 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 3.99e-05 | 182 | 93 | 5 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 182 | 93 | 5 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-05 | 183 | 93 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.10e-05 | 183 | 93 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 183 | 93 | 5 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.10e-05 | 183 | 93 | 5 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 183 | 93 | 5 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-05 | 183 | 93 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 184 | 93 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| Drug | allo-threonine | 1.00e-05 | 119 | 94 | 6 | CID000000205 | |
| Drug | mycobactin | 1.29e-05 | 35 | 94 | 4 | CID005748534 | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 1.35e-05 | 189 | 94 | 7 | 6960_UP | |
| Drug | Tenoxicam [59804-37-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.60e-05 | 194 | 94 | 7 | 4182_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.83e-05 | 198 | 94 | 7 | 6651_UP | |
| Disease | myopathy (implicated_via_orthology) | 4.07e-07 | 48 | 92 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | collagen disease (implicated_via_orthology) | 6.32e-06 | 12 | 92 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Bartter disease type 4B | 9.62e-06 | 2 | 92 | 2 | cv:C4310805 | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 9.62e-06 | 2 | 92 | 2 | C1839884 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 9.62e-06 | 2 | 92 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 9.62e-06 | 2 | 92 | 2 | C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 9.62e-06 | 2 | 92 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | Bartter disease type 4b (is_implicated_in) | 9.62e-06 | 2 | 92 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 9.62e-06 | 2 | 92 | 2 | 613090 | |
| Disease | Bartter disease (implicated_via_orthology) | 9.62e-06 | 2 | 92 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | Leiomyoma, Epithelioid | 9.62e-06 | 2 | 92 | 2 | C0086533 | |
| Disease | Proteinuria | 9.95e-06 | 43 | 92 | 4 | C0033687 | |
| Disease | Alport syndrome (is_implicated_in) | 2.88e-05 | 3 | 92 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | Alport syndrome | 2.88e-05 | 3 | 92 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 2.88e-05 | 3 | 92 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 5.75e-05 | 4 | 92 | 2 | C0241908 | |
| Disease | Alport Syndrome | 5.75e-05 | 4 | 92 | 2 | C1567741 | |
| Disease | azoospermia (implicated_via_orthology) | 8.13e-05 | 27 | 92 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | 2'-O-methylcytidine measurement | 9.56e-05 | 5 | 92 | 2 | EFO_0800635 | |
| Disease | Alport Syndrome, X-Linked | 9.56e-05 | 5 | 92 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 9.56e-05 | 5 | 92 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 9.56e-05 | 5 | 92 | 2 | C1567744 | |
| Disease | Schizophrenia | PLSCR4 MAG NTRK3 HLA-E DAO SIRPB1 SBNO2 SLC6A9 SLC6A11 CSNK1E PAK2 | 9.58e-05 | 883 | 92 | 11 | C0036341 |
| Disease | Bartter syndrome | 1.43e-04 | 6 | 92 | 2 | cv:C0004775 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 2.00e-04 | 7 | 92 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | QRS duration | 3.48e-04 | 298 | 92 | 6 | EFO_0005055 | |
| Disease | Colorectal Carcinoma | 3.48e-04 | 702 | 92 | 9 | C0009402 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 4.26e-04 | 10 | 92 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 6.22e-04 | 12 | 92 | 2 | EFO_1001304 | |
| Disease | Opioid use measurement | 9.83e-04 | 15 | 92 | 2 | EFO_0009937 | |
| Disease | third ventricle volume measurement | 9.83e-04 | 15 | 92 | 2 | EFO_0010335 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 1.42e-03 | 18 | 92 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | Malignant neoplasm of breast | 1.90e-03 | 1074 | 92 | 10 | C0006142 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 2.13e-03 | 22 | 92 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | Renal glomerular disease | 2.33e-03 | 23 | 92 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.33e-03 | 23 | 92 | 2 | C4521256 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMSWYTPMPIKKGSV | 166 | Q6ZRH7 | |
| GWLIPMQLMSYPLSE | 356 | P23141 | |
| KSYWLSTTAPIPMMP | 1541 | Q14031 | |
| MVTPVTWMDNPIEVY | 1 | O42043 | |
| YWLSTPALMPMNMAP | 1521 | Q01955 | |
| EDYLMSMVWKRTPAG | 516 | O60242 | |
| IRMMYGVSPWGDSPI | 476 | Q13085 | |
| PNMTWMIQVPRIYDV | 451 | P23109 | |
| PKDLTYRPMSDMGWG | 586 | Q9UBL3 | |
| SKMNPLWNTMVIGGY | 146 | P28070 | |
| VMMSIWPYLQKIDPT | 56 | Q8NHS3 | |
| QPGRGQIMKVDAPWM | 196 | P14920 | |
| KYMNSGPVVAMVWEG | 66 | P22392 | |
| TMVGTPYWMAPEVVT | 436 | O75914 | |
| LMGPRRYMGLVVTTW | 136 | Q9GZK7 | |
| LAYIWMPTPDMSTEG | 226 | O95278 | |
| MVPRAPWMEQEGSEY | 66 | P13747 | |
| KWPLGAPMLAAIYAM | 6 | O43300 | |
| GMPMEFYSIIWNPLT | 86 | O43194 | |
| SVMYAPWKPTVNGTM | 321 | P20916 | |
| WMPPESIMYRKFTTE | 736 | Q16288 | |
| RTGYWTMMNIPPVEK | 136 | Q5H9T9 | |
| PLQMVYKMPCGQWLP | 1061 | Q5HYC2 | |
| LPGYLKPETMVMMWT | 431 | P83111 | |
| SGFYPKPVWVMWMRG | 226 | P06126 | |
| GKYPMPNQSVPITWM | 86 | Q9NRQ2 | |
| YKMMQGGVGIPTIRW | 56 | P48730 | |
| DPGMSTKMWNIAITY | 1801 | Q5H8C1 | |
| PQMMGKPLYWGADRS | 231 | Q86SU0 | |
| TGMKSVTGTPYWMSP | 516 | Q9Y2U5 | |
| PRMNEWSYVAKMSEP | 421 | Q9P2J3 | |
| MYDVTPPGVVMGLAW | 756 | P36776 | |
| RRPPWSYEMSKEQLM | 131 | P36915 | |
| TLSPENGYWVVIMMK | 681 | O15553 | |
| VKEVMDTWTRQMGYP | 531 | Q07075 | |
| VDISGMKVPWLYVGM | 461 | P29375 | |
| ELNSMGIWYRMGRVP | 181 | Q9H7P6 | |
| MPAITWYKDGQPIMS | 1576 | Q96RW7 | |
| CVAVGSPMPYVKWMQ | 266 | Q13332 | |
| SPMPYVKWMQGAEDL | 271 | Q13332 | |
| TQGPKPEMVYDFWRM | 961 | Q92729 | |
| RSTMVGTPYWMAPEV | 421 | Q13153 | |
| GTPYWMAPEVVTRKA | 426 | Q13153 | |
| EQSKRSTMVGTPYWM | 396 | Q13177 | |
| STMVGTPYWMAPEVV | 401 | Q13177 | |
| NPNLATYMKPEMWGK | 386 | Q99613 | |
| YPKPVWVMWMRGEQE | 236 | P15812 | |
| MVTPVTWMDNPIEVY | 1 | P61566 | |
| MVTPVTWMDNPIEIY | 1 | P61567 | |
| VWYMPPMTREEGEDA | 366 | Q53EU6 | |
| YWSQDISTMMPKPPI | 331 | Q92562 | |
| VSMGIWMAAIGPKRY | 441 | Q8NCR0 | |
| PIKNWSPMRLQMYSG | 326 | Q6PGQ7 | |
| SYWLSTPEPMPMSMQ | 1536 | P29400 | |
| SPPATYRWKMNGTEM | 66 | Q02246 | |
| IMVWQIPDYTPMRNI | 106 | Q6QEF8 | |
| MVTPVTWMDNPIEVY | 1 | Q9HDB8 | |
| PPMTWKWIVGPMFLY | 266 | P04839 | |
| ILGKPVMERWETPYM | 36 | Q14353 | |
| GKVNPPAADMKYMIW | 46 | Q6UWM5 | |
| RSYWTMLMGQQEPAK | 1666 | Q9Y238 | |
| MYMKGVSSVEVQWIP | 991 | Q8IY37 | |
| KPMVILPYMNWGNLK | 406 | P34925 | |
| MGLYIVRTVNEPWTM | 746 | Q8N1G2 | |
| VGAPMPYVKWMMGAE | 256 | P10586 | |
| TCVAVGSPMPYVKWM | 256 | P23468 | |
| GSPMPYVKWMLGAED | 261 | P23468 | |
| AYRKQMRGMPTFPWD | 296 | O00204 | |
| WPMPRMFSKAPITYV | 281 | Q8IYX7 | |
| KYMNSGPVVAMVWEG | 51 | O60361 | |
| MSIYQAMWKGVLRPG | 4911 | P58107 | |
| KSYRPSSMEPWMEPL | 1621 | P48634 | |
| EPRNMIYMSRLGIWG | 426 | Q9Y2G9 | |
| KVWMTFPYGRMDPSS | 336 | Q8N3P4 | |
| IGNKMMRARQYPWGT | 246 | Q14141 | |
| WTYPMRREMQEILPG | 21 | Q8WUJ0 | |
| APKRPMSAYMLWLNA | 546 | Q08945 | |
| MTIPYGWAKRPMLQR | 266 | Q8WTS1 | |
| PPLMEWMRVAITYAE | 421 | Q8N961 | |
| RLMKWIMFPVGYGVP | 461 | Q9BY15 | |
| MREFGTNWPVYMTKP | 106 | P32320 | |
| WMLILATTIPMPAGY | 411 | P51800 | |
| WMLILATTIPMPAGY | 411 | P51801 | |
| IWRYMSRPVMSGPGL | 86 | O95406 | |
| IRWMPPEAIMYGKFS | 656 | Q01973 | |
| MTSLIPVGPIMWFRG | 56 | O00241 | |
| MKTMDPGYPKPITVW | 466 | P51512 | |
| DYVKLMMPSWMTPAQ | 126 | A6NFA1 | |
| MWYVPVGIMFLVGSK | 266 | P43007 | |
| MSEEQRQWMYKNVPP | 41 | Q9UJC5 | |
| LGMEPRYARPEWMIV | 236 | P24928 | |
| SFIGTPYWMAPEVVM | 191 | O94804 | |
| KQGMIPRRYVMPWKE | 41 | Q6ZNM6 | |
| PSWPGVYRLSMSLME | 1391 | Q5SRE5 | |
| VWRISPMFKGVGYGM | 171 | P48067 | |
| AYPKAVTMMPLSPLW | 381 | P48066 | |
| MKIELSMQPWNPGYS | 1 | P57060 | |
| FPWMLNMEPYTVSGM | 1906 | Q9UPU5 | |
| VTDMMLQDKPYPDWG | 171 | Q9H0C3 | |
| MTKQPGNLRWMAPEV | 621 | Q59H18 | |
| DKHWIMQYTGPMLPI | 256 | Q8IWU6 | |
| ISLPVPALEMMYIWN | 451 | Q5SRH9 | |
| YKMMQGGVGIPSIKW | 56 | P49674 | |
| DMYPKTWSGMLVGAL | 441 | Q03721 |